Evidence map›Paper›PMID 27627128›Full record

ArticlePloS one2016

A Genome-Wide siRNA Screen Implicates Spire1/2 in SipA-Driven Salmonella Typhimurium Host Cell Invasion.

Daniel Andritschke, Sabrina Dilling, Mario Emmenlauer, Tobias Welz, Fabian Schmich, Benjamin Misselwitz, Pauli Rämö, Klemens Rottner, Eugen Kerkhoff, Teiji Wada and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Infection strategies ofGut microbes reports · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Swiss Army Pathogen: TheFrontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Daniel AndritschkeInstitute of Microbiology, Eidgenössische Technische Hochschule Zurich, CH-8093, Zurich, Switzerland.
Sabrina DillingInstitute of Microbiology, Eidgenössische Technische Hochschule Zurich, CH-8093, Zurich, Switzerland.
Mario EmmenlauerBiozentrum, University of Basel, CH-4056, Basel, Switzerland.
Tobias WelzDepartment of Neurology, University of Regensburg, DE- 93040, Regensburg, Germany.
Fabian SchmichDepartment of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, CH-4058, Basel, Switzerland.
Benjamin MisselwitzInstitute of Microbiology, Eidgenössische Technische Hochschule Zurich, CH-8093, Zurich, Switzerland.
Pauli RämöBiozentrum, University of Basel, CH-4056, Basel, Switzerland.
Klemens RottnerZoological Institute, Technische Universität Braunschweig, D-38106, Braunschweig, Germany.
Eugen KerkhoffDepartment of Neurology, University of Regensburg, DE- 93040, Regensburg, Germany.
Teiji WadaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), A-1030, Vienna, Austria.
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), A-1030, Vienna, Austria.
Niko BeerenwinkelDepartment of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, CH-4058, Basel, Switzerland.
Peter HorvathLight Microscopy Center, Eidgenössische Technische Hochschule Zurich, CH-8093, Zurich, Switzerland.
Christoph DehioBiozentrum, University of Basel, CH-4056, Basel, Switzerland.
Wolf-Dietrich HardtInstitute of Microbiology, Eidgenössische Technische Hochschule Zurich, CH-8093, Zurich, Switzerland.
ETH Zurich · CHUniversity of Basel · CHAustrian Academy of Sciences · ATUniversity of Regensburg · DEBoard of the Swiss Federal Institutes of Technology · CHTechnische Universität Braunschweig · DEUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella Typhimurium (S. Tm) is a leading cause of diarrhea. The disease is triggered by pathogen invasion into the gut epithelium. Invasion is attributed to the SPI-1 type 3 secretion system (T1). T1 injects effector proteins into epithelial cells and thereby elicits rearrangements of the host cellular actin cytoskeleton and pathogen invasion. The T1 effector proteins SopE, SopB, SopE2 and SipA are contributing to this. However, the host cell factors contributing to invasion are still not completely understood. To address this question comprehensively, we used Hela tissue culture cells, a genome-wide siRNA library, a modified gentamicin protection assay and S. TmSipA, a sopBsopE2sopE mutant which strongly relies on the T1 effector protein SipA to invade host cells. We found that S. TmSipA invasion does not elicit membrane ruffles, nor promote the entry of non-invasive bacteria "in trans". However, SipA-mediated infection involved the SPIRE family of actin nucleators, besides well-established host cell factors (WRC, ARP2/3, RhoGTPases, COPI). Stage-specific follow-up assays and knockout fibroblasts indicated that SPIRE1 and SPIRE2 are involved in different steps of the S. Tm infection process. Whereas SPIRE1 interferes with bacterial binding, SPIRE2 influences intracellular replication of S. Tm. Hence, these two proteins might fulfill non-redundant functions in the pathogen-host interaction. The lack of co-localization hints to a short, direct interaction between S. Tm and SPIRE proteins or to an indirect effect.

Indexed as

AnimalsBacterial ProteinsCell LineFluorescent Antibody TechniqueGenome-Wide Association StudyHeLa CellsHost-Pathogen InteractionsHumansMiceMicrofilament ProteinsNuclear ProteinsReal-Time Polymerase Chain ReactionRNA, Small InterferingSalmonella typhimuriumBacterial ProteinsMicrofilament ProteinsNuclear ProteinsRNA, Small InterferingSipA protein, SalmonellaSPIRE1 protein, humanSPIRE2 protein, human

Identifiers

PMID27627128
PMCPMC5023170
OpenAlexW2519436393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.